ATE283060T1 - Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen - Google Patents

Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen

Info

Publication number
ATE283060T1
ATE283060T1 AT01961557T AT01961557T ATE283060T1 AT E283060 T1 ATE283060 T1 AT E283060T1 AT 01961557 T AT01961557 T AT 01961557T AT 01961557 T AT01961557 T AT 01961557T AT E283060 T1 ATE283060 T1 AT E283060T1
Authority
AT
Austria
Prior art keywords
treatment
hormone
compound containing
associated diseases
pollen extract
Prior art date
Application number
AT01961557T
Other languages
English (en)
Inventor
Kaj Winter
Christer Hedman
Lars Kaernerud
Original Assignee
Natumin Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natumin Pharma Ab filed Critical Natumin Pharma Ab
Application granted granted Critical
Publication of ATE283060T1 publication Critical patent/ATE283060T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Insects & Arthropods (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Medical Informatics (AREA)
  • Animal Husbandry (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
AT01961557T 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen ATE283060T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0003092A SE0003092D0 (sv) 2000-09-01 2000-09-01 New Use
PCT/SE2001/001851 WO2002017944A1 (en) 2000-09-01 2001-08-31 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders

Publications (1)

Publication Number Publication Date
ATE283060T1 true ATE283060T1 (de) 2004-12-15

Family

ID=20280860

Family Applications (5)

Application Number Title Priority Date Filing Date
AT01963652T ATE283061T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen
AT01961557T ATE283060T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen
AT01961556T ATE286739T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme
AT01961554T ATE283058T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
AT01961555T ATE283059T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von reizbarkeit

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT01963652T ATE283061T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-enthaltenden verbindung zur behandlung von ödemen

Family Applications After (3)

Application Number Title Priority Date Filing Date
AT01961556T ATE286739T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-haltigen verbindung zur behandlung erkrankungsbedingter gewichtszunahme
AT01961554T ATE283058T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von dysphorie
AT01961555T ATE283059T1 (de) 2000-09-01 2001-08-31 Verwendung einer pollenextrakt-hältigen verbindung zur behandlung von reizbarkeit

Country Status (10)

Country Link
EP (5) EP1313492B1 (de)
JP (5) JP2004507508A (de)
AT (5) ATE283061T1 (de)
AU (7) AU2001282814B2 (de)
CA (5) CA2424146A1 (de)
DE (5) DE60107441D1 (de)
NO (1) NO330691B1 (de)
PL (1) PL202468B1 (de)
SE (1) SE0003092D0 (de)
WO (5) WO2002017942A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005139150A (ja) * 2003-11-10 2005-06-02 Api Co Ltd エストロゲン様作用剤及びその製造方法、並びに骨粗しょう症予防剤及び飲食品
US7887851B2 (en) * 2004-06-07 2011-02-15 Kao Corporation Aromatase activator
CN104027100A (zh) * 2014-06-12 2014-09-10 山东中弘信息科技有限公司 一种基于最近历史值的血压异常数据处理方法
KR101533197B1 (ko) * 2014-09-18 2015-07-02 성균관대학교산학협력단 부테인을 포함하는 부종의 예방 또는 치료용 조성물
FR3055215B1 (fr) * 2016-08-31 2020-02-14 S.A.M. Serelys Pharma Composition comprenant des extraits de pollen et /ou de pistils
CN106138856A (zh) * 2016-09-30 2016-11-23 四川易创生物科技有限公司 一种治疗经间期出血的新型中药组合物及制备方法
EP3335717A1 (de) * 2016-12-13 2018-06-20 Serelys Pharma S.A.M. Zusammensetzung zur verwendung bei der behandlung von symptomen im zusammenhang mit prämenstruellem syndrom (pms)
FR3070263B1 (fr) * 2017-08-28 2020-07-24 Serelys Pharma S A M Composition pour son utilisation dans le traitement et/ou la prevention de l’infertilite

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2970957B2 (ja) * 1991-05-15 1999-11-02 株式会社グレイトチレン 精製花粉栄養調整物
ES2081255B1 (es) * 1994-01-05 1996-09-01 Ind Farma Especial Aplicacion de las proteinas receptoras de autoincompatibilidad (slsg) de plantas para el tratamiento de las enfermedades alergicas.
US5569459A (en) * 1995-02-15 1996-10-29 Bio-Virus Research Incorporated Pharmaceutical compositions for the management of premenstrual syndrome and alleviation of menopausal disorders
JPH09278665A (ja) * 1996-04-10 1997-10-28 Api Kk 花粉エキスソフトカプセル剤及びその製造方法
KR100669875B1 (ko) * 1998-02-23 2007-01-16 다이요 가가꾸 가부시끼가이샤 테아닌 함유 조성물

Also Published As

Publication number Publication date
WO2002017942A1 (en) 2002-03-07
WO2002017941A1 (en) 2002-03-07
NO330691B1 (no) 2011-06-14
SE0003092D0 (sv) 2000-09-01
AU2001284581B2 (en) 2006-09-21
AU2001282814B2 (en) 2006-12-21
DE60107441D1 (de) 2004-12-30
EP1313494B1 (de) 2005-01-12
EP1313493A1 (de) 2003-05-28
EP1313492B1 (de) 2004-11-24
JP2004507507A (ja) 2004-03-11
NO20030988D0 (no) 2003-03-03
PL202468B1 (pl) 2009-06-30
EP1313496A1 (de) 2003-05-28
DE60107444T2 (de) 2005-12-08
EP1313495B1 (de) 2004-11-24
AU8281401A (en) 2002-03-13
ATE286739T1 (de) 2005-01-15
CA2420906A1 (en) 2002-03-07
EP1313492A1 (de) 2003-05-28
JP2004507510A (ja) 2004-03-11
CA2424146A1 (en) 2002-03-07
ATE283059T1 (de) 2004-12-15
AU2001282813A1 (en) 2002-03-13
ATE283058T1 (de) 2004-12-15
DE60107442D1 (de) 2004-12-30
WO2002017940A1 (en) 2002-03-07
CA2420906C (en) 2014-07-15
ATE283061T1 (de) 2004-12-15
EP1313495A1 (de) 2003-05-28
JP4896354B2 (ja) 2012-03-14
WO2002017944A1 (en) 2002-03-07
WO2002017943A1 (en) 2002-03-07
CA2424011A1 (en) 2002-03-07
EP1313496B1 (de) 2004-11-24
CA2420823A1 (en) 2002-03-07
AU8458101A (en) 2002-03-13
AU2001282815A1 (en) 2002-03-13
PL360652A1 (en) 2004-09-20
CA2424026A1 (en) 2002-03-07
CA2420823C (en) 2014-07-15
JP2004507509A (ja) 2004-03-11
JP2004507506A (ja) 2004-03-11
AU2001282816A1 (en) 2002-03-13
DE60107443D1 (de) 2004-12-30
DE60108402D1 (de) 2005-02-17
DE60107444D1 (de) 2004-12-30
EP1313493B1 (de) 2004-11-24
JP2004507508A (ja) 2004-03-11
EP1313494A1 (de) 2003-05-28
NO20030988L (no) 2003-03-03

Similar Documents

Publication Publication Date Title
EP0249735A3 (de) Als aktives Mittel 2-Phenyl-1,2-benzisoselenazol-3(2H)-on enthaltende pharmazeutische Zubereitungen zur Behandlung von durch oxidativen Stress verursachten Krankheiten
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
EA200201000A1 (ru) Гормон-заместительная терапия
EE05287B1 (et) Tsklopentanoindoolid, nende kasutamine ravimi valmistamiseks ning neid sisaldav farmatseutiline kompositsioon
WO1997048391A3 (en) Methods and compositions comprising r-ibuprofen
BR0317104A (pt) Composições farmacêuticas dispersáveis
IL154888A (en) Aqueous Pharmaceutical Gel Preparation Containing At least One Vitamin D or One Vitamin D Analog At least One Corticosteroid
DE59710177D1 (de) Omega-3-fettsäurehaltige zubereitung aus mikroorganismen als prophylaktikum bzw. therapeutikum gegen kokzidiose bei tieren
HUP0100539A2 (hu) D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására
BRPI0414215A (pt) tienopirazóis
DE60016798D1 (de) Papiertuch enthaltend antivirale wirkstoffe die hautfreundlich sind
AU2002214389A1 (en) Pharmaceutical composition containing honey for the treatment of wounds
ATE283060T1 (de) Verwendung einer pollenextrakt-haltigen verbindung zur behandlung hormon-assoziierter erkrankungen
BR9914644A (pt) Composições tamponadas para diálise
DK1343472T3 (da) Thixotropisk næsespray
WO2001043705A3 (en) Compositions containing a retinoid and a stilbene for skin care
EE200100689A (et) IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon
ATE304374T1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
AU9184901A (en) Use of il-6r/il-6 chimera in huntington's disease
YU24603A (sh) Novi farmaceutski preparati koji sadrže epinastin i pseudoefedrin
ATE259778T1 (de) Nicht-hygroskopische salze aktiver inhaltsstoffe, die therapeutische und/oder ernährungsphysiologische eigenschaften haben und oral verabreichbare zusammensetzungen, die diese enthalten
JPS568324A (en) Infectious disease remedy for external and ophthalmologic application
Chandrashekar Comparative study on the efficacy of Topical Curcumin as a gel and as Buccal Mucoadhesive Patch in the management of oral Submucous Fibrosis-A clinicobiochemical evaluation
UA40495A (uk) Склад для лікування захворювань ясен
MD2230G2 (ro) Unguent sulfurat

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties